Speaking to CNBC-TV18, Gautam Chhaochharia said that he expects an earnings growth of around 10 percent for the fiscal year 2017 and sees a strong fourth quarter for the pharma sector on a year-on-year basis.
first published: Apr 13, 2016 07:57 pm
A collection of the most-viewed Moneycontrol videos.
Sensex, Nifty resume rally after 2-day pause, financials shine bright | Closing Bell
Maran Govindasamy of Unifi Capital on Investment Insights from India’s Consumption Story
Nifty Bulls Likely To Tread With Caution With Eye On Axis Bank Q2 Earnings |Opening Bell Live
Live: Nifty slips below 25,200, LG Electronics shares down after blockbuster debut | Closing Bell
